Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison F Smith

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacoeconomics|March 5, 2018
The Role of Measurement Uncertainty in Health Technology Assessments (HTAs) of In Vitro TestsAlison F Smith, Mike Messenger, Peter Hall, et al.
Chemical Communications (Cambridge, England)|May 1, 2015
Synthesis of hollow and trimetallic nanostructures by seed-mediated co-reductionRebecca G Weiner, Alison F Smith, Sara E Skrabalak
Nanoscale|June 28, 2016
Engineering high refractive index sensitivity through the internal and external composition of bimetallic nanocrystalsAlison F Smith, Samantha M Harvey, Sara E Skrabalak, et al.
Clinical Chemistry|August 25, 2019
Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical OutcomesAlison F Smith, Bethany Shinkins, Peter S Hall, et al.
BMC Health Services Research|October 30, 2022
An exploratory assessment of the impact of a novel risk assessment test on breast cancer clinic waiting times and workflow: a discrete event simulation modelAlison F Smith, Samuel N Frempong, Nisha Sharma, et al.
Journal of the American Chemical Society|January 20, 2005
Resist-free patterning of surface architectures in polymer-based microanalytical devicesRobin L McCarley, Bikas Vaidya, Suying Wei, et al.
Clinical Chemistry and Laboratory Medicine|May 27, 2024
Applying the Milan models to setting analytical performance specifications - considering all the informationGraham R D Jones, Katy J L Bell, Ferruccio Ceriotti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2021
Setting analytical performance specifications using HbA1c as a model measurandTze Ping Loh, Alison F Smith, Katy J L Bell, et al.
Health Technology Assessment (Winchester, England)|June 5, 2018
The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisationPeter S Hall, Elizabeth D Mitchell, Alison F Smith, et al.
Health Technology Assessment (Winchester, England)|April 15, 2017
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancerHisham Mehanna, Chris C McConkey, Joy K Rahman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacoeconomics|March 5, 2018
The Role of Measurement Uncertainty in Health Technology Assessments (HTAs) of In Vitro TestsAlison F Smith, Mike Messenger, Peter Hall, et al.
Chemical Communications (Cambridge, England)|May 1, 2015
Synthesis of hollow and trimetallic nanostructures by seed-mediated co-reductionRebecca G Weiner, Alison F Smith, Sara E Skrabalak
Nanoscale|June 28, 2016
Engineering high refractive index sensitivity through the internal and external composition of bimetallic nanocrystalsAlison F Smith, Samantha M Harvey, Sara E Skrabalak, et al.
Clinical Chemistry|August 25, 2019
Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical OutcomesAlison F Smith, Bethany Shinkins, Peter S Hall, et al.
BMC Health Services Research|October 30, 2022
An exploratory assessment of the impact of a novel risk assessment test on breast cancer clinic waiting times and workflow: a discrete event simulation modelAlison F Smith, Samuel N Frempong, Nisha Sharma, et al.
Journal of the American Chemical Society|January 20, 2005
Resist-free patterning of surface architectures in polymer-based microanalytical devicesRobin L McCarley, Bikas Vaidya, Suying Wei, et al.
Clinical Chemistry and Laboratory Medicine|May 27, 2024
Applying the Milan models to setting analytical performance specifications - considering all the informationGraham R D Jones, Katy J L Bell, Ferruccio Ceriotti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2021
Setting analytical performance specifications using HbA1c as a model measurandTze Ping Loh, Alison F Smith, Katy J L Bell, et al.
Health Technology Assessment (Winchester, England)|June 5, 2018
The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisationPeter S Hall, Elizabeth D Mitchell, Alison F Smith, et al.
Health Technology Assessment (Winchester, England)|April 15, 2017
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancerHisham Mehanna, Chris C McConkey, Joy K Rahman, et al.
Pageof 2